The Cell Cycle Inhibitor p16INK4A Sensitizes Lymphoblastic Leukemia Cells to Apoptosis by Physiologic Glucocorticoid Levels
Open Access
- 1 April 2001
- journal article
- Published by Elsevier
- Vol. 276 (14) , 10984-10989
- https://doi.org/10.1074/jbc.m008188200
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- c-Myc does not prevent glucocorticoid-induced apoptosis of human leukemic lymphoblastsOncogene, 1999
- Bcl-2 interferes with the execution phase, but not upstream events, in glucocorticoid-induced leukemia apoptosisOncogene, 1999
- The interleukin 1β‐converting enzyme inhibitor CrmA prevents Apo1/Fas‐ but not glucocorticoid‐induced poly(ADP‐ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cellsFEBS Letters, 1997
- Cancer Cell CyclesScience, 1996
- Role of the INK4a Locus in Tumor Suppression and Cell MortalityCell, 1996
- Inactivation of the p15INK4Band p16INK4Genes in Hematologic MalignanciesLeukemia & Lymphoma, 1996
- Transcriptional Activation by Tetracyclines in Mammalian CellsScience, 1995
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- Thymocyte apoptosis induced by elevated endogenous corticosterone levelsEuropean Journal of Immunology, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993